From Surf Wiki (app.surf) — the open knowledge base
Plantar fibromatosis
Thickening of the feet's deep connective tissue (fascia)
Thickening of the feet's deep connective tissue (fascia)
| Field | Value |
|---|---|
| name | Plantar fibromatosis |
| synonyms | Ledderhose's disease |
| image | Autosomal dominant - en.svg |
| caption | This condition is inherited in an autosomal dominant manner |
Plantar fascial fibromatosis, also known as Ledderhose's disease, Morbus Ledderhose, and plantar fibromatosis, is a relatively uncommon non-malignant thickening of the feet's deep connective tissue, or fascia. In the beginning, where nodules start growing in the fascia of the foot, the disease is minor. Over time, walking becomes painful. The disease is named after Georg Ledderhose, a German surgeon who described the condition for the first time in 1894. A similar disease is Dupuytren's disease, which affects the hand and causes bent hand or fingers.
As in most forms of fibromatosis, it is usually benign and its onset varies with each patient. The nodules are typically slow-growing
In 2020, the World Health Organization reclassified plantar fibromatosis as a specific type of tumor in the category of intermediate (locally aggressive) fibroblastic and myofibroblastic tumors.
Signs and symptoms
Plantar fibromatosis is most frequently present on the medial border of the sole, near the highest point of the arch. The lump is usually painless and the only pain experienced is when the nodule rubs on the shoe or floor. The overlying skin is freely movable, and contracture of the toes does not occur in the initial stages.

The typical appearance of plantar fibromatosis on magnetic resonance imaging (MRI) is a poorly defined, infiltrative mass in the aponeurosis next to the plantar muscles.
Only 25% of patients show symptoms on both feet (bilateral involvement). The disease may also infiltrate the dermis or, very rarely, the flexor tendon sheath.
Risk factors
The histological and ultrastructural features of Ledderhose and Dupuytren's disease are the same, which supports the hypothesis that they have a common cause and pathogenesis.
There are certain identified risk factors. The disease is more commonly associated with:
- A family history of the disease
- Higher incidence in males
- Palmar fibromatosis 10–65% of the time.
- Peyronie's disease
- Epilepsy patients
- Diabetes mellitus
There is also a suspected, although unproven, link between incidence and alcoholism, smoking, liver diseases, thyroid problems, and stressful work involving the feet.
Diagnosis
A combination of physical examination of the arch and plantar fascia, as well as ultrasound imaging by a physician is the usual path to diagnosis.
An MRI (Magnetic Resonance Imaging) scan is usually the imaging of choice to determine between other possible conditions such as ganglion cysts. MRI tends to be more accurate than x-ray or ultrasound, showing the full extent of the condition.
Treatment
Although the origin of the disease is unknown, there is speculation that it is an aggressive healing response to small tears in the plantar fascia, almost as if the fascia over-repairs itself following an injury. There is also some evidence that it might be genetic.
In the early stages, when the nodule is single and/or smaller, it is recommended to avoid direct pressure to the nodule(s). Soft inner soles on footwear and padding may be helpful.
MRI and sonogram (diagnostic ultrasound) are effective in showing the extent of the lesion, but cannot reveal the tissue composition. Even then, recognition of the imaging characteristics of plantar fibromatoses can help in the clinical diagnosis.
Surgery of Ledderhose's disease is difficult because tendons, nerves, and muscles are located very closely to each other. Additionally, feet have to carry heavy load, and surgery might have unpleasant side effects. If surgery is performed, the biopsy is predominantly cellular and frequently misdiagnosed as fibrosarcoma. Since the diseased area (lesion) is not encapsulated, clinical margins are difficult to define. As such, portions of the diseased tissue may be left in the foot after surgery. Inadequate excision is the leading cause of recurrence.
Radiotherapy has been shown to reduce the size of the nodules and reduce the pain associated with them. It is approximately 80% effective, with minimal side effects.
Post-surgical radiation treatment may decrease recurrence. There has also been variable success in preventing recurrence by administering gadolinium. Skin grafts have been shown to control the recurrence of the disease.
Extracorporeal shock wave therapy (ESWT) has, in some cases, been reported to significantly reduce pain and improve walking ability in patients with plantar fibromatosis. Collagenase injection, FDA-approved for Dupuytren's contracture with favorable outcomes, showed no benefit in a reported case of plantar fibromatosis. Cryotherapy has also been reported as an effective treatment for Ledderhose disease, with an approximate 80% success rate and potentially lower recurrence than conventional surgery.
Cortisone injections, such as triamcinolone,
Topical verapamil is also used to treat plantar fibromatosis.
References
References
- "OMIM Entry - % 126900 - DUPUYTREN CONTRACTURE".
- (2003). "MRI diagnosis of plantar fibromatosis—a rare anatomic location". The Foot.
- (1894). "Über Zerreisungen der Plantarfascie". Arch Klin Chir.
- "Dupuytren's contracture - Patient UK".
- "Plantar fibromatosis". Bunion Busters.
- (October 2001). "The Vikings and Baron Dupuytren's disease". Baylor University Medical Center Proceedings.
- (April 2021). "The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives". Pathologica.
- "Plantar fibromatosis". Dept of Radiology and Radiological Sciences, Uniformed Services University.
- "Ledderhose Disease: plantar fibromatosis". Wheeless' Textbook of Orthopaedics.
- "Dupuytren's Contracture and Plantar Fibromatosis".
- "Plantar Fibromatosis aka Ledderhose Disease - Foot Pain Explored".
- (March 2022). "Radiotherapy for patients with Ledderhose disease: Long-term effects, side effects and patient-rated outcome". Radiotherapy and Oncology.
- (2020). "Risk perception of coronavirus disease 2019 (COVID-19) and its related factors among college students in China during quarantine". PLOS ONE.
- (2019). "Advanced Diagnostic Approaches for Necrotrophic Fungal Pathogens of Temperate Legumes with a Focus on Botrytis SPP". Frontiers in Microbiology.
- (September 2014). "Collagenase Clostridium histolyticum injection for plantar fibromatosis (Ledderhose disease)". Plastic and Reconstructive Surgery.
- (2011). "Dupuytren's Disease and Related Hyperproliferative Disorders: Principles, Research, and Clinical Perspectives". Springer.
- "Ledderhose disease".
- Grenfell S, Borg M. (2014). "Radiotherapy in fascial fibromatosis: a case series, literature review and considerations for treatment of early-stage disease". J Med Imaging Radiat Oncol.
- (January 2010). "Radiation therapy for early stages of morbus Ledderhose". Strahlentherapie und Onkologie.
- (2015). "Patient-reported outcomes after electron radiation treatment for early-stage palmar and plantar fibromatosis". Practical Radiation Oncology.
- (2018-12-17). "The etiology, evaluation, and management of plantar fibromatosis". Orthopedic Research and Reviews.
- (February 2013). "Point-Counterpoint: Is Conservative Care The Best Approach For Plantar Fibromatosis?".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Plantar fibromatosis — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report